Powerful Medical
16. June 2023

Powerful Medical Wins the Venture Capital Deal of the Year Award!

We are thrilled to announce that Powerful Medical has been awarded the esteemed title of Venture Capital Deal of the Year at the CVCA & SLOVCA Awards competition. This recognition is a testament to our team’s dedication and the significant strides we’ve made in the past year.

Our sincere gratitude goes to our venture capital partners Venture To Future Fund, bpd partners, and CB ESPRI Impact One, whose faith in our vision and robust support has been instrumental in realising this achievement. Your investment and partnership have fueled our progress, transforming our ambitious vision into innovative solutions that became a reality.

We would also like to extend our appreciation to our esteemed partners, Kinstellar, for their invaluable legal support and Mazars for their thorough due diligence, which contributed greatly to this deal’s success.

While we are deeply honored by this award, we view it not as a final destination but as a significant milestone in our journey. This recognition reaffirms our commitment to our mission: to revolutionize cardiology with the power of AI. It fuels our determination to continue our research and development to ultimately enhance and preserve the lives of cardiac patients around the world.

As we move forward, we remain focused on our goal of expanding our impact and reach. With our incredible team, supportive partners, and a constant drive to innovate, we are excited about what the future holds for Powerful Medical. Here’s to improving lives, one heartbeat at a time. A special thank you goes to our Head of Data, Michal Martoňák, for accepting this award on behalf of the whole team!

To conclude, we would like to thank everyone who supported us along the way.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

Share this article

Don't miss these

Wellens syndrom ECG - Blog

Facing Wellens’ Syndrome: Are You Prepared to Prevent Acute Coronary Occlusions?

Wellens' Syndrome is a condition representing a reperfusion state post coronary artery occlusion, marked by distinctive ECG changes. This condition demands urgent recognition and intervention to prevent the progression to an extensive anterior wall myocardial infarction (MI).

Gearing Up for the US Market: PMcardio Showcases at ACC.24

We're thrilled to share our experience at the American College of Cardiology's 24th annual meeting (ACC.24) in Atlanta, where we showcased our AI-powered ECG interpretation platform

Join 25,000 healthcare professionals who are already taking advantage of AI